It is commonly believed that the combination of antidepressant medications (ADM) and psychotherapy is more efficacious in the treatment of depression than either treatment alone. There is evidence that adding cognitive therapy (CT) enhances the initial effects of ADM, but most of the relevant studies have suffered from low power. Findings from numerous studies also suggest that CT has an enduring effect, but most of the evidence has been relevant to the prevention of relapse - the return of symptoms associated with the treated episode. There is little evidence on the more critical prevention question: whether prior exposure to CT prevents recurrence - the onset of new episodes. What is needed is a study with power sufficient to detect the benefits that might accompany the addition of CT to ADM, and that can address the attendant cost-effectiveness questions. Over the last few years we have randomized 450 depressed outpatients (150 at each of three sites) to ADM alone or to ADM plus CT. All patients are treated to remission and then to recovery (allowing up to 18 months in each phase) with up to four different classes of antidepressant medications plus augmentation, as clinically indicated. A random half of the patients receive CT in addition to medications. Recovered patients are then assigned randomly to either maintenance medications or medication withdrawal;patients in the combined condition are withdrawn from ongoing CT. Patients are then followed for a three-year period for the purpose of detecting recurrences. The main hypotheses are that: (1) rates of remission and recovery will be higher in the combined treatment relative to ADM alone;and (2) prior exposure to CT will protect against recurrence following medication withdrawal. At this point, intake is complete, and 450 patients have been randomized to treatment. Estimated rates of remission (75% of all assigned) and recovery (83% of those who reach remission) have been strong, and over 150 recovered patients have entered the maintenance phase to date. Completion of this trial will allow for powerful tests of treatment effects with respect to remission, recovery, and recurrence, as well as the exploration of underlying mechanisms (mediation) and the delineation of patient-type by treatment interactions (moderation) that can be used to refine treatment guidelines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH060998-09
Application #
7777761
Study Section
Interventions Committee for Adult Mood and Anxiety Disorders (ITMA)
Program Officer
Pearson, Jane L
Project Start
1999-12-01
Project End
2012-02-29
Budget Start
2010-03-01
Budget End
2011-02-28
Support Year
9
Fiscal Year
2010
Total Cost
$351,720
Indirect Cost
Name
University of Pennsylvania
Department
Psychiatry
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Furukawa, Toshi A; Weitz, Erica S; Tanaka, Shiro et al. (2017) Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials. Br J Psychiatry 210:190-196
Cooper, Andrew A; Strunk, Daniel R; Ryan, Elizabeth T et al. (2016) The therapeutic alliance and therapist adherence as predictors of dropout from cognitive therapy for depression when combined with antidepressant medication. J Behav Ther Exp Psychiatry 50:113-9
Vittengl, Jeffrey R; Jarrett, Robin B; Weitz, Erica et al. (2016) Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression. Am J Psychiatry 173:481-90
Lorenzo-Luaces, Lorenzo; German, Ramaris E; DeRubeis, Robert J (2015) It's complicated: The relation between cognitive change procedures, cognitive change, and symptom change in cognitive therapy for depression. Clin Psychol Rev 41:3-15
Hollon, Steven D; DeRubeis, Robert J; Fawcett, Jan et al. (2014) Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry 71:1157-64
Derubeis, Robert J; Gelfand, Lois A; German, Ramaris E et al. (2014) Understanding processes of change: how some patients reveal more than others-and some groups of therapists less-about what matters in psychotherapy. Psychother Res 24:419-28
DeRubeis, Robert J; Cohen, Zachary D; Forand, Nicholas R et al. (2014) The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration. PLoS One 9:e83875
Cuijpers, Pim; Weitz, Erica; Twisk, Jos et al. (2014) Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an ""individual patient data"" meta-analysis. Depress Anxiety 31:941-51
Lorenzo-Luaces, Lorenzo; DeRubeis, Robert J; Webb, Christian A (2014) Client characteristics as moderators of the relation between the therapeutic alliance and outcome in cognitive therapy for depression. J Consult Clin Psychol 82:368-73
Amsterdam, Jay D; Luo, Lola; Shults, Justine (2013) Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder. Br J Psychiatry 202:301-6

Showing the most recent 10 out of 22 publications